Show Summary Details
Page of

Oesophageal cancer 

Oesophageal cancer
Chapter:
Oesophageal cancer
Author(s):

Melissa Thomas

, Karin Haustermans

, Eric Van Cutsem

, Piet Dirix

, Xavier Sagaert

, Christophe M. Deroose

, Philippe Nafteux

, Hans Prenen

, and Toni Lerut

DOI:
10.1093/med/9780199656103.003.0036_update_002

Updates

New AJCC/IUCC TNM edition (8th ed.).

Discussion of the use of proton beam therapy in oesophageal cancer.

Discussion of peri-operative chemotherapy versus preoperative chemoradiotherapy in patients with an adenocarcinoma.

Update of ongoing trials and the results of recently published trials.

Updated on 29 March 2019. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 August 2019

Worldwide, oesophageal cancer, including cancer of the gastro-oesophageal junction (GEJ), is the sixth leading cause of death from cancer. Despite recent advances, treatment of oesophageal cancer remains challenging and is best approached by an experienced multidisciplinary team. Surgery alone is the treatment of choice in early stage carcinoma although in superficial cancers (T1a) endoscopic resection is to be preferred. In locally advanced tumours induction therapy followed by surgery is the preferred treatment. In selected cases definitive chemoradiotherapy could be considered as a valuable alternative. The role of adjuvant chemotherapy is unclear, but could be considered for selected GEJ adenocarcinoma patients. Adjuvant chemoradiotherapy should be considered in all patients with advanced disease or positive margins who did not receive neo-adjuvant radiotherapy. For metastatic disease, the goal is to prolong and maximize quality of life. Regarding the palliative treatment of dysphagia, brachytherapy was shown to be more effective than stenting.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.